Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

NCT00872417 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

750

Enrollment

OTHER

Sponsor class

Conditions

Acquired Immune Deficiency Syndrome
HIV Infections

Interventions

DRUG: first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT)
DRUG: second line ARV therapy (3TC+TDF+LPV/RTV)

Sponsor

Peking Union Medical College

Collaborators

[object Object]